JacoboEnriqueMintzerMD
Geriatrics • Charleston, SCExecutive Director of Clinical Research and the Alzheimer
Are you Dr. Mintzer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-724-2018
Summary
- Dr. Jacobo Mintzer, MD is a geriatrician in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, Florida, and Pennsylvania. He is affiliated with Ralph H. Johnson Veterans Affairs Medical Center, Roper Hospital, and Roper St. Francis Mount Pleasant Hospital.
Education & Training
University of Buenos AiresClass of 1979
Certifications & Licensure
SC State Medical License 1992 - 2025
PA State Medical License 1988 - 2024
FL State Medical License 1989 - 2000- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
- Citalopram for Agitation in Alzheimer's Disease Start of enrollment: 2009 Jul 01
- Apathy in Dementia Methylphenidate Trial (ADMET) Start of enrollment: 2010 Jun 01
- The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Start of enrollment: 2014 Jan 08
- Join now to see all
Publications & Presentations
PubMed
- 197 citationsRandomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s DiseaseK. Ranga Rama Krishnan, H. Cecil Charles, P. Murali Doraiswamy, Jacobo Mintzer, Richard H. Weisler
The American Journal of Psychiatry. 2003-11-01 - 216 citationsAnticholinergic side-effects of drugs in elderly people.Jacobo Mintzer, Alistair Burns
Journal of the Royal Society of Medicine. 2000-09-01 - 20 citationsChange in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.Paul B. Rosenberg, Lea T. Drye, Anton P. Porsteinsson, Bruce G. Pollock, Devangere P. Devanand
International Psychogeriatrics. 2015-08-25
Press Mentions
- Press Release: MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USCAugust 9th, 2022
- Stimulant Drug May Reduce Apathy in People with Alzheimer’s DiseaseOctober 18th, 2021
- ADHD Med May Reduce Apathy in Alzheimer’s DiseaseOctober 5th, 2021
- Join now to see all
Grant Support
- Apathy In Alzheimer'S Disease Methylphenidate TrialNational Institute On Aging2009–2010
- Institute For Research Minority Training On Mental HealthNational Institute On Aging2006–2007
- Depressoin In Alzheimer'S Disease Study-2 (Diads-2)National Institute Of Mental Health2003–2007
- Institute For Research Minority Training On Mental Heal*National Institute On Aging2002–2005
- Caregiving For Alzheimers PatientsNational Institute On Aging1994–1996
- Caregiving For Hispanic Alzheimer'S PatientsNational Institute On Aging1992–1993
